Saturday 17 October 2026 Export CNMD’s income statement to Excel — free account

CONMED Corporation

CONMED Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 5.18% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 11.6%, free cash flow grew 46.0% and total debt fell 5.40%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.

46.72 0.42 −0.89%

Follow CNMD

Alert me

Market cap: $1.4B
P/E: 25.3×
Fwd P/E: 8.8×
Dividend yield: 0.00%
F-score: 5/9
Altman Z: 1.86
Beneish M: −2.70
Dividend safety: 63/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

CONMED Corporation (CNMD) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, CONMED Corporation (CNMD) trades at a P/E ratio of 25.3×. Over the past ten years it has ranged from 0.0× (June 2023) to 5,641× (December 2020); the current reading is higher than 27% of that period. That is above the Medical Devices industry median of 23.2× and above the Healthcare sector median of 23.0×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/CNMD/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="CONMED Corporation P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/CNMD/metrics/pe-ratio">CONMED Corporation (CNMD) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	26.9×	68.54%
FY2024	16.0×	(69.43%)
FY2023	52.2×	—
FY2022	0.0×	—
FY2021	66.2×	(80.48%)
FY2020	339×	209.56%
FY2019	110×	149.33%
FY2018	44.0×	72.90%
FY2017	25.4×	(70.07%)
FY2016	85.0×	112.21%

Period	P/E ratio	Change
Jun 2026	17.7×	(11.44%)
Mar 2026	20.0×	(25.70%)
Dec 2025	26.9×	17.77%
Sep 2025	22.8×	56.06%
42 more quarters	Free account

Against its own ten years

Low 0.0× High 5,641×

Ten-year median 46.5×

Current reading's percentile 22

Company	P/E ratio
AORT Artivion, Inc. compare	n/m
ESTA Establishment Labs Holdings Inc. compare	n/m
NVCR NovoCure Limited compare	n/m
ENOV Enovis Corporation compare	n/m
TNDM Tandem Diabetes Care, Inc. compare	n/m
ATEC Alphatec Holdings, Inc. compare	n/m
BVS Bioventus Inc. compare	16.4×
CNMD CONMED Corporation	25.3×
IRMD iRadimed Corporation compare	48.5×
Medical Devices industry median	23.2×
Healthcare sector median	23.0×
Market median	18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

CONMED Corporation (CNMD) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on CNMD

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on CNMD

Stockrow Weekly